Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastases.

Eriksson H, Zebary A, Vassilaki I, Omholt K, Ghaderi M, Hansson J.

JAMA Dermatol. 2015 Apr;151(4):410-6. doi: 10.1001/jamadermatol.2014.3689.

PMID:
25588152
2.

KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.

Zebary A, Omholt K, Vassilaki I, Höiom V, Lindén D, Viberg L, Kanter-Lewensohn L, Johansson CH, Hansson J.

J Dermatol Sci. 2013 Dec;72(3):284-9. doi: 10.1016/j.jdermsci.2013.07.013. Epub 2013 Aug 8.

PMID:
23993026
3.

KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases.

Zebary A, Jangard M, Omholt K, Ragnarsson-Olding B, Hansson J.

Br J Cancer. 2013 Aug 6;109(3):559-64. doi: 10.1038/bjc.2013.373. Epub 2013 Jul 16.

4.

Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL study.

Zebary A, Omholt K, van Doorn R, Ghiorzo P, Harbst K, Hertzman Johansson C, Höiom V, Jönsson G, Pjanova D, Puig S, Scarra GB, Harland M, Olsson H, Egyhazi Brage S, Palmer J, Kanter-Lewensohn L, Vassilaki I, Hayward NK, Newton-Bishop J, Gruis NA, Hansson J; Melanoma Genetics Consortium (GenoMEL).

J Invest Dermatol. 2014 Jan;134(1):287-290. doi: 10.1038/jid.2013.270. Epub 2013 Jun 14. No abstract available.

5.

KIT pathway alterations in mucosal melanomas of the vulva and other sites.

Omholt K, Grafström E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK.

Clin Cancer Res. 2011 Jun 15;17(12):3933-42. doi: 10.1158/1078-0432.CCR-10-2917.

6.

No evidence of RALGDS mutations in cutaneous melanoma.

Omholt K, Hansson J.

Melanoma Res. 2007 Dec;17(6):410-2. No abstract available.

PMID:
17992125
7.

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

Edlundh-Rose E, Egyházi S, Omholt K, Månsson-Brahme E, Platz A, Hansson J, Lundeberg J.

Melanoma Res. 2006 Dec;16(6):471-8.

PMID:
17119447
8.

Mutations of PIK3CA are rare in cutaneous melanoma.

Omholt K, Kröckel D, Ringborg U, Hansson J.

Melanoma Res. 2006 Apr;16(2):197-200.

PMID:
16567976
9.

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.

Clin Cancer Res. 2003 Dec 15;9(17):6483-8.

10.
11.

Associations of MHC class II alleles in Norwegian primary Sjögren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen.

Nakken B, Jonsson R, Brokstad KA, Omholt K, Nerland AH, Haga HJ, Halse AK.

Scand J Immunol. 2001 Oct;54(4):428-33.

12.

Supplemental Content

Loading ...
Support Center